NCT07479628 2026-03-18
Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma
Shanghai Chest Hospital
Phase 2 Not yet recruiting
Clinical Trials
11 trialsNCT04913311 2026-02-19
Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Recruiting
NCT06810609 2026-01-27
InDuRanS
University Hospital, Bonn
Phase 2 Recruiting
NCT07264647 2025-12-04
Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)
Fondazione Ricerca Traslazionale
Phase 2 Recruiting
NCT04305613 2025-10-02
CLARITY
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT07200154 2025-09-30
Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC
Peking University Cancer Hospital & Institute
Phase 2 Not yet recruiting
NCT06448910 2025-09-24
Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLC
Fudan University
Phase 2 Active not recruiting
NCT02788461 2025-09-18
PET-BOOST
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Active not recruiting
NCT06998719 2025-05-31
ACCESS
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT06944470 2025-04-25
JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC
Shanghai Junshi Bioscience Co., Ltd.
Phase 2 Not yet recruiting
NCT06908070 2025-04-03
CROWD
Amsterdam UMC, location VUmc
Phase 4 Recruiting